InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Hogge Gary S., Officier. Officer active across 1 companies, notably Lineage Cell Therapeutics, Inc.. Aggregated, 2 reports have been published. The latest transaction was disclosed on 28 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€112,975185,000 shares@ €0.61070.028% mcap100.0% of flow
Common Shares, no par value
SEC:0001493152-21-032897·
€112,975185,000 shares@ €0.61070.028% mcap50.0% of flow
Common Shares, no par value
SEC:0001493152-21-032897:0·
2 of 2 declarations
About Hogge Gary S.
Gary S. Hogge is Senior Vice President of Clinical and Medical Affairs at Lineage Cell Therapeutics, Inc. He is responsible for the strategic direction of the company's clinical and medical initiatives. Hogge plays a key role in optimizing processes and improving clinical outcomes. His expertise in regenerative medicine is an asset for Lineage.
